Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHTCF.L Regulatory News (HTCF)

  • There is currently no data for HTCF

Update on Continuation Proposals

14 Jan 2016 07:00

RNS Number : 8126L
BlueCrest AllBlue Fund Ltd
14 January 2016
Β 

ο»Ώ

Β 

BlueCrest AllBlue Fund Limited (the "Company")

14 January 2016

Update on Continuation Proposals

Further to the Company's announcement on 9 December 2015, the Board is pleased to announce that, having completed its review of manager proposals received by the Company and consulted with its major shareholders, it proposes to recommend the replacement of its existing management arrangements with a mandate given to J.P. Morgan Asset Management ("JPMAM") group(1). The proposed appointment is subject to, amongst other things, detailed due diligence which is being performed on behalf of the Company and finalisation of engagement terms. In addition, the proposed appointment will be subject to shareholder approval as part of the re-organisation proposals (the "Proposals") to be put forward in due course.

As part of the Proposals, it is intended that the Company will invest substantially all of its assets (net of the cash exit opportunity described below) in the Highbridge Multi-Strategy Fund ("HMSF"). HMSF is a global multi-strategy hedge fund, managed by Highbridge Capital Management ("HCM"), focused on relative value strategies with idiosyncratic sources of return that invests in 12 distinct strategies across Fundamental Equity, Quantitative Equity, Event Driven Equity, Capital Structure Arbitrage, Convertible & Volatility Arbitrage, Fundamental Credit and Macro. Since its inception (1 January 1993) HMSF has achieved 10.76% annualised net returns, 6.89% annualised volatility and low beta relative to equity and credit indices.(2)

The JPMAM group is the largest manager of closed-end investment companies in the UK with 23 investment companies under its management and Β£9.2bn of assets under management(3). HCM was founded in 1992 as one of the industry's first multi-strategy hedge fund managers. Today, it is a global alternative investment manager with $29 billion in AUM(4). HCM maintains a staff of over 380 employees, including ~150 investment professionals and has offices in London, New York and Hong Kong.(4) HCM established a strategic partnership with JPMAM in 2004. All investment, capital allocation and risk management decisions for HMSF are independent of JPMAM.

It is currently intended to put forward the Proposals by the end of January/early February. As previously announced, the Proposals will provide shareholders with an opportunity to receive a full cash exit at NAV less costs (the "Cash Exit"), representing the net realisation proceeds from the AllBlue Limited redemptions, as soon as practicable following receipt by the Company. Proceeds of AllBlue Limited assets not capable of immediate realisation will subsequently be invested into HMSF with the exception of those proceeds due to shareholders pursuant to the Cash Exit.

Following implementation of the Proposals, it is intended to introduce a quarterly redemption facility, for up to 20% of the prevailing net asset value of the Company at NAV less costs, which may be implemented at the Board's discretion in each quarterly period. It is intended that net redemption proceeds would be paid to shareholders as soon as practicable following receipt by the Company.

A further announcement in relation to the Proposals will be made in due course.

For further information contact:

JTC (Guernsey) Limited, Secretary

Tel: +44 (0) 1481 702 400

Jefferies International Limited

Gary Gould/ Alex Collins

Tel: + 44 (0) 20 7029 8000

Dexion Capital Plc

Robin Bowie/ Katie Standley

Tel: +44 (0) 20 7832 0900

Β 

Β 

PAST PERFORMANCE IS NOT NECESSARILY INDICATIVE OF FUTURE RESULTS

There can be no assurance that the Company's or HMSF's return objectives will be realized or that the Company or HMSF will not experience losses.

Β 

(1) The brand name for the Asset Management business of J.P. Morgan Chase & Co.

(2) As of 30 November 2015 net of all applicable fees and expenses. Returns are estimated and unaudited for 2015.

(3) As of 31 December 2015.

(4) As of 1 December 2015.

Β 

Β 

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
STRUOUKRNWAAAAR
Date   Source Headline
1st Nov 20232:02 pmRNSCompany Update
27th Oct 20235:30 pmRNSHighbridge Tactical Credit Fund
18th Oct 20231:37 pmRNSCompany Update
3rd Oct 20239:36 amRNSDirector Declaration
28th Apr 20232:33 pmRNSTotal Voting Rights
17th Apr 20237:00 amRNSShares in issue
30th Mar 20235:02 pmRNSHalf-year Report
29th Mar 20232:11 pmRNSReturn of Capital
29th Mar 20232:08 pmRNSCash Distribution
17th Mar 20234:35 pmRNSPrice Monitoring Extension
17th Mar 20237:00 amRNSDirector Declaration
16th Mar 20237:00 amRNSCompany Update and Return of Capital Information
15th Mar 20234:36 pmRNS2019 Redemption Portfolio
15th Mar 20234:30 pmRNSNet Asset Value(s)
7th Mar 20234:35 pmRNSPrice Monitoring Extension
13th Feb 20239:00 amRNSChange of Registered Office
2nd Dec 202211:44 amRNSResult of AGM
21st Nov 20223:05 pmRNSHolding(s) in Company
9th Nov 20227:00 amRNSNotice of AGM
8th Nov 20224:00 pmRNSNet Asset Value(s)
8th Nov 20224:00 pmRNS2019 Redemption Portfolio
7th Nov 20225:00 pmRNS2019 Redemption Portfolio
7th Nov 20224:58 pmRNSNet Asset Value(s)
2nd Nov 20227:00 amRNSDistribution
31st Oct 20223:22 pmRNSAnnual Financial Report
20th Oct 202210:47 amRNSAudit Opinion
18th Oct 202211:04 amRNSNet Asset Value(s)
18th Oct 202211:03 amRNS2019 Redemption Portfolio
25th Aug 20224:50 pmRNSNet Asset Value(s)
25th Aug 20224:41 pmRNS2019 Redemption Portfolio
1st Aug 20229:51 amRNS2019 Redemption Portfolio
1st Aug 20229:45 amRNSNet Asset Value(s)
5th Jul 202211:09 amRNS2019 Redemption Portfolio
5th Jul 202211:03 amRNSNet Asset Value(s)
1st Jun 202211:22 amRNSNet Asset Value(s)
1st Jun 202211:20 amRNS2019 Redemption Portfolio
7th Apr 20228:38 amRNSNet Asset Value(s)
7th Apr 20228:24 amRNS2019 Redemption Portfolio
25th Mar 202211:22 amRNSNet Asset Value(s)
25th Mar 202211:15 amRNS2019 Redemption Portfolio
22nd Mar 202211:00 amRNSCash Exit Payment
21st Mar 20223:02 pmRNSInterim Report and Accounts
2nd Mar 202210:23 amRNS2019 Redemption Portfolio
2nd Mar 202210:20 amRNSNet Asset Value(s)
23rd Feb 20224:40 pmRNSSecond Price Monitoring Extn
23rd Feb 20224:36 pmRNSPrice Monitoring Extension
21st Feb 202211:21 amRNSHolding(s) in Company
20th Jan 20225:22 pmRNSHolding(s) in Company
6th Jan 20225:06 pmRNS2019 Redemption Portfolio
6th Jan 20224:59 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.